Pharmaceutical News and Articles

Depressed Adolescents Twice as Likely to Take Up Vaping

A survey of Australian adolescents finds those who are experiencing depressive symptoms have double the risk of taking up vaping. In the short term, nicotine ma

Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds

The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. using se

Global Study Reveals Widespread Micronutrient Deficiencies

More than 5 billion people globally do not consume enough iodine, vitamin E, and calcium, according to a study published online Aug. 29 in The Lancet Global Hea

KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema

Hormone Therapy Tied to Less Biological Aging in Postmenopausal Women

Postmenopausal women who use hormone therapy (HT) are biologically younger than those not receiving HT, according to a study published online Aug. 29 in JAMA Ne

SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in Th

Time From Drug Approval to Reimbursement Longer in U.S. Than Some European Countries

Time from approval to reimbursement of new drugs varies between countries and is shortest in Switzerland and Germany, both of which include health technology as

Semaglutide Does Not Increase Psychiatric Complications in Overweight, Obesity

Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation behavior among adults with overweight or obesit

Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

Telix Submits NDA for TLX101-CDx (Pixclara) Brain Cancer Imaging Agent